LARSX is founded in 1995, operates from its headquarter in Helena, Montana 59601, US. The company operates in the Business Services, Research & Development sector.
LARSX specializes in Artificial intelligence (AI), Therapeutic drug discovery, Quantum chemistry, Machine learning, Artificial General Intelligence (AGI) development, Immunotherapy, Peptidomimetics, Optoelectronic analog supercomputers, Parallel processing, OS design, and offers services including Octopus Neural System (ONS), Super Turing chip implementation, and Smart molecules for novel immunotherapies and peptidomimetics.